KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Invested Capital (2016 - 2025)

Historic Invested Capital for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $84.5 billion.

  • Novartis Ag's Invested Capital rose 807.13% to $84.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $84.5 billion, marking a year-over-year increase of 807.13%. This contributed to the annual value of $84.5 billion for FY2025, which is 807.13% up from last year.
  • Novartis Ag's Invested Capital amounted to $84.5 billion in Q4 2025, which was up 807.13% from $7.5 billion recorded in Q3 2025.
  • Novartis Ag's Invested Capital's 5-year high stood at $105.3 billion during Q4 2021, with a 5-year trough of $5.5 billion in Q3 2023.
  • Its 5-year average for Invested Capital is $27.8 billion, with a median of $8.5 billion in 2024.
  • As far as peak fluctuations go, Novartis Ag's Invested Capital tumbled by 3142.26% in 2022, and later surged by 2960.97% in 2023.
  • Over the past 5 years, Novartis Ag's Invested Capital (Quarter) stood at $105.3 billion in 2021, then fell by 13.89% to $90.7 billion in 2022, then fell by 15.98% to $76.2 billion in 2023, then rose by 2.57% to $78.2 billion in 2024, then rose by 8.07% to $84.5 billion in 2025.
  • Its Invested Capital was $84.5 billion in Q4 2025, compared to $7.5 billion in Q3 2025 and $8.3 billion in Q2 2025.